Prognostic factors for survival in systemic lupus erythematosus associated pulmonary hypertension

Lupus

Volumn 21, Issue 4, 2012, Pages 353-364

  Chow, S L ^a   Chandran, V ^a   Fazelzad, R ^a   Johnson, S R ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Prognosis; pulmonary arterial hypertension; review; survival; systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; ESTROGEN; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY;

CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; INFECTION; LUNG ARTERY PRESSURE; LUNG EMBOLISM; LUNG TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MORTALITY; PATIENT MONITORING; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; PULMONARY VASCULITIS; QUALITY CONTROL; RAYNAUD PHENOMENON; REVIEW; SURVIVAL PREDICTION; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS ASSOCIATED PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; THROMBOCYTOPENIA; THROMBOSIS;

DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION, PULMONARY; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84858639463     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311429815     Document Type: Review

References (71)

1. Asherson RA, Hackett D, Gharavi AE. Pulmonary hypertension in systemic lupus erythematosus: a report of three cases. J Rheumatol. 1986 ; 13: 416-420 (Pubitemid 16034602)
2. Asherson RA, Higenbottam TW, Dinh Xuan AT, Khamashta MA, Hughes GR. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol. 1990 ; 17: 1292-1298 (Pubitemid 20382853)
3. Chung SM, Lee CK, Lee EY, Yoo B, Lee SD, Moon HB. Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension. Clin Rheumatol. 2006 ; 25: 866-872 (Pubitemid 44473155)
4. Quismorio FP. Clinical and pathologic features of lung involvement in systemic lupus erythematosus. Semin Resp Med. 1988 ; 9: 297-304
5. Li EK, Tam LS. Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients. J Rheumatol. 1999 ; 26: 1923-1929 (Pubitemid 30007058)
6. Winslow TM, Ossipov MA, Fazio GP, Simonson JS, Redberg RF, Schiller NB. Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J. 1995 ; 129: 510-515
7. Johnson SR, Granton JT. Scleroderma and systemic lupus associated pulmonary hypertension: How are they different?. European Resp Rev. 2011 ;:
8. Johnson SR, Gladman DD, Urowitz MB, Ibanez D, Granton JT. Pulmonary hypertension in systemic lupus. Lupus. 2004 ; 13: 506-509 (Pubitemid 39071203)
9. Fisher MR, Mathai SC, Champion HC, et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum. 2006 ; 54: 3043-3050 (Pubitemid 44497786)
10. Kasukawa R, Nishimaki T, Takagi T, Miyawaki S, Yokohari R, Tsunematsu T. Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study. Clin Rheumatol. 1990 ; 9: 56-62 (Pubitemid 20225580)
11. Ji YQ, Zhang ZL, Lu WX. [The clinical analysis of pulmonary arterial hypertension in connective tissue disease]. Chung Hua Nei Ko Tsa Chih. 2006 ; 45: 467-471
12. Roncoroni AJ, Alvarez C, Molinas F. Plexogenic arteriopathy associated with pulmonary vasculitis in systemic lupus erythematosus. Respiration. 1992 ; 59: 52-56
13. Chen CH, Chen HA, Wang HP, Liao HT, Chou CT, Huang DF. Pulmonary arterial hypertension in autoimmune diseases: an analysis of 19 cases from a medical center in northern Taiwan. J Microbiol Immunol Infect. 2006 ; 39: 162-168
14. Groen H, Bootsma H, Postma DS, Kallenberg CG. Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide. J Rheumatol. 1993 ; 20: 1055-1057 (Pubitemid 23203252)
15. Gurubhagavatula I, Palevsky HI. Pulmonary hypertension in systemic autoimmune disease. Rheum Dis Clin North Am. 1997 ; 23: 365-394 (Pubitemid 27230726)
16. Kanemoto N, Gonda N, Katsu M, Fukuda J. Case report. Two cases of pulmonary hypertension with Raynaud's phenomenon. Primary pulmonary hypertension and systemic lupus erythematosus. Jpn Heart J. 1975 ; 16: 354-360
17. Lavras Costallat LT, Valente Coimbra AM. Raynaud's phenomenon in systemic lupus erythematosus. Rev Rheum Engl Ed. 1995 ; 62: 349-353
18. Quismorio FP, Sharma O, Koss M, et al. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum. 1984 ; 13: 349-359 (Pubitemid 14079399)
19. Rubin LA, Geran A, Rose TH, Cohen H. A fatal pulmonary complication of lupus in pregnancy. Arthritis Rheum. 1995 ; 38: 710-714
20. Shen JY, Chen SL, Wu YX, et al. Pulmonary hypertension in systemic lupus erythematosus. Rheumatol Int. 1999 ; 18: 147-151
21. Simonson JS, Schiller NB, Petri M, Hellmann DB. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol. 1989 ; 16: 918-925 (Pubitemid 19220204)
22. Robbins IM, Gaine SP, Schilz R, Tapson VF, Rubin LJ, Loyd JE. Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus. Chest. 2000 ; 117: 14-18 (Pubitemid 30053613)
23. Asherson RA, Mackworth-Young CG, Boey ML, et al. Pulmonary hypertension in systemic lupus erythematosus. Br Med J (Clin Res Ed). 1983 ; 287: 1024-1025 (Pubitemid 13009251)
24. Boumpas DT, Austin HA, Fessler BJ, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med. 1995 ; 122: 940-950
25. Horn CA. Pulmonary hypertension and autoimmune disease. Chest. 1993 ; 104: 279-280
26. Fois E, Le Guern V, Dupuy A, Humbert M, Mouthon L, Guillevin L. Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: retrospective analysis of 93 patients. Clin Exp Rheumatol. 2010 ; 28: 836-841
27. Kim WU, Min JK, Lee SH, Park SH, Cho CS, Kim HY. Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study. Clin Exp Rheumatol. 1999 ; 17: 539-545
28. Condliffe R, Kiely DG, Peacock AJ, et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med. 2009 ; 179: 151-157
29. Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med. 2006 ; 144: 427-437 (Pubitemid 46768164)
30. Tegzova D, Kamenik L, Musilova L, et al. [The incidence and course of pulmonary hypertension in systemic lupus erythematosus patients. Three years follow up outcome]. Ceska Revmatologie. 2003 ; 11: 117-127 (Pubitemid 37258880)
31. Bautista GG, Cabral A, Achurra AF. [Pulmonary hypertension in generalized lupus erythematosus]. Rev Med Panama. 1992 ; 17: 23-27
32. Semeniuk GB, Re R, Freue RD. [Thrombosis of great pulmonary vessels causing severe pulmonary hypertension in systemic lupus erythematosus]. Medicina (B Aires). 2001 ; 61: 319-321 (Pubitemid 33040185)
33. Jiang Y, Zhao Y, Xu WB, Tang FL. [Pulmonary thromboembolism in systemic lupus erythematosus: clinical analysis of 11 cases]. Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao. 2002 ; 24: 329-331
34. Goldman J, Edwards WD. Plexogenic pulmonary hypertension in systemic lupus erythematosus: Report of two cases and review of the literature. Cardiovasc Pathol. 1994 ; 3: 65-69 (Pubitemid 24087036)
35. McMillan E, Martin WL, Waugh J, et al. Management of pregnancy in women with pulmonary hypertension secondary to SLE and anti-phospholipid syndrome. Lupus. 2002 ; 11: 392-398 (Pubitemid 34760639)
36. Schwartzberg M, Lieberman DH, Getzoff B, Ehrlich GE. Systemic lupus erythematosus and pulmonary vascular hypertension. Arch Intern Med. 1984 ; 144: 605-607 (Pubitemid 14152746)
37. Horn EM, Barst RJ, Poon M. Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus. Chest. 2000 ; 118: 1229-1230
38. Miller MH. Pulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill: another report. Ann Rheum Dis. 1987 ; 46: 159-161 (Pubitemid 17015723)
39. Jungers P, Dougados M, Pélissier C, et al. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 616-624
40. Kawamura N, Tsutsui H, Fukuyama K, et al. Severe pulmonary hypertension in a patient with systemic lupus erythematosus and minimal lupus activity. Intern Med. 2002 ; 41: 109-112 (Pubitemid 34223712)
41. Koyama S, Ichiyoshi T, Chino M, Kanbayashi T. Systemic lupus erythematosus with pulmonary hypertension. Intern Med. 1996 ; 35: 39-42 (Pubitemid 126484022)
42. Marchesoni A, Messina K, Carrieri P, Sinigaglia L, Tosi S. Pulmonary hypertension and systemic lupus erythematosus. Clin Exp Rheumatol. 1983 ; 1: 247-250 (Pubitemid 14210285)
43. Matsumoto N, Yamada A, Harada S, et al. [A case of lupus erythematosus preceded by right heart failure due to pulmonary hypertension]. Kokyu To Junkan. 1991 ; 39: 1037-1041
44. Ebrahim RA, Jamsheer A, Al-Banna R, Al-Qari H. Pulmonary hypertension in SLE - A case report. Bahrain Medical Bulletin. 1999 ; 21: 27-29 (Pubitemid 29237241)
45. Menon MA, Wang F, Ng SC. Primary pulmonary hypertension in systemic lupus erythematosus. Singapore Med J. 1985 ; 26: 544-549 (Pubitemid 16108222)
46. Denton CP, Humbert M, Rubin L, Black CM. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions. Ann Rheum Dis. 2006 ; 65: 1336-1340 (Pubitemid 44620443)
47. Pines A, Kaplinsky N, Olchovsky D, Rozenman J, Frankl O. Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Prognostic and therapeutic implications. Chest. 1985 ; 88: 129-135 (Pubitemid 15073591)
48. James TN. Thrombi in antrum atrii dextri of human heart as clinically important source of chronic microembolisation to lungs. Br Heart J. 1983 ; 49: 122-132 (Pubitemid 13112055)
49. Luo RQ, Lei YX, Zhang X, Liang F. [Clinical analysis of patients with systemic lupus erythematosus and concomitant pulmonary hypertension]. Nan Fang Yi Ke Da Xue Xue Bao. 2008 ; 28: 1860-1863
50. Johnson SR, Swinton JR, Granton JT. Prognostic factors for survival in scleroderma associated pulmonary arterial hypertension. J Rheumatol. 2008 ; 35: 1584-1590
51. Swiston JR, Johnson SR, Granton JT. Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature. Respir Med. 2010 ; 104: 1588-1607
52. Greenstone MA. Delayed diagnosis of systemic lupus erythematosus associated pulmonary hypertension. Br J Rheumatol. 1991 ; 30: 391-391
53. Pietra GG, Edwards WD, Kay JM, et al. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation. 1989 ; 80: 1198-1206 (Pubitemid 19282508)
54. Fulmer JD, Kaltreider HB. The pulmonary vasculitides. Chest. 1982 ; 82: 615-624 (Pubitemid 13234194)
55. Asherson RA, Oakley CM. Pulmonary hypertension and systemic lupus erythematosus. J Rheumatol. 1986 ; 13: 1-5 (Pubitemid 16118712)
56. The connective tissue diseases. 2 nd ed. Oxford: Blackwell Scientific, 1983. Hughes GRV, ed. Oxford: Blackwell Scientific ; 1983 :
57. Badui E, Garcia-Rubi D, Robles E, et al. Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology. 1985 ; 36: 431-441 (Pubitemid 15247819)
58. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998 ; 31: 1650-1657 (Pubitemid 28273311)
59. Funauchi M, Shimadzu H, Tamaki C, et al. Survival study by organ disorders in 306 Japanese patients with systemic lupus erythematosus: results from a single center. Rheumatol Int. 2007 ; 27: 243-249 (Pubitemid 46091525)
60. Goupille P, Fauchier L, Babuty D, Fauchier JP, Valat JP. Precapillary pulmonary hypertension dramatically improved with high doses of corticosteroids during systemic lupus erythematosus. J Rheumatol. 1994 ; 21: 1976-1977 (Pubitemid 24312672)
61. Kawaguchi Y, Hara M, Harigai M, Sakurada M, Nakamura H, Kashiwazaki S. Corticosteroid pulse therapy in a patient with SLE and pulmonary hypertension. Clin Exp Rheumatol. 1998 ; 16: 510-510
62. Karmochkine M, Wechsler B, Godeau P, Brenot F, Jagot JL, Simonneau G. Improvement of severe pulmonary hypertension in a patient with SLE. Ann Rheum Dis. 1996 ; 55: 561-562 (Pubitemid 26249043)
63. Turner A, Samanta A, Nichol FE. Primary pulmonary hypertension associated with systemic lupus erythematosus. Clin Rheumatol. 1991 ; 10: 320-322
64. Sanchez O, Sitbon O, Jaïs X, Simonneau G, Humbert M. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest. 2006 ; 130: 182-189 (Pubitemid 44116858)
65. Jais X, Launay D, Yaici A, et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum. 2008 ; 58: 521-531 (Pubitemid 351294886)
66. Minai O. An update in pulmonary hypertension in systemic lupus erythematosus - do we need to know about it?. Lupus. 2009 ; 18: 92-92
67. Pope J. An update in pulmonary hypertension in systemic lupus erythematosus - do we need to know about it?. Lupus. 2008 ; 17: 274-277 (Pubitemid 351655792)
68. Yoshio T, Masuyama J, Mimori A, Takeda A, Minota S, Kano S. Endothelin-1 release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosus. Ann Rheum Dis. 1995 ; 54: 361-365
69. Haas C. [Pulmonary hypertension associated with systemic lupus erythematosus]. Bull Acad Natl Med. 2004 ; 188: 985-997 (Pubitemid 40081463)
70. Heresi GA, Minai OA. Lupus-associated pulmonary hypertension: long-term response to vasoactive therapy. Respir Med. 2007 ; 101: 2099-2107 (Pubitemid 47324254)
71. Kim P, Grossman JM. Treatment of mixed connective tissue disease. Rheum Dis Clin North Am. 2005 ; 31: 549-565 (Pubitemid 41111555)